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High alcohol intake is an independent risk factor for upper gastrointestinal (GI) tract 
cancers. In particular, there is increasing evidence that acetaldehyde, the first metabolite of 
ethanol, might be responsible for ethanol-associated carcinogenesis; it may be produced by 
mucosal alcohol dehydrogenases present in the upper digestive tract and especially by 
alcohol oxidation by oral bacterial microflora. Cysteine, a nonessential amino acid, has 
been shown to be able to react covalently with acetaldehyde to form 2-methylthiazolidine-
4-carboxylic acid, thereby reducing its concentration. On the other hand, chlorhexidine, a 
well known antimicrobial agent, is widely used in antiseptic mouthwashes to reduce oral 
bacteria and it is therefore able to prevent acetaldehyde production. The aim of our work 
has been to develop buccoadhesive formulations (tablets) containing both L-cysteine and 
chlorhexidine diacetate and to verify their ability to reduce oral acetaldehyde produced after 
alcoholic drinks consumption. In an in-vitro system, the formulations prepared were able to 
release gradually their active principles and to neutralize acetaldehyde concentrations 
comparable to those ones present in saliva of heavy drinkers. Similarly, the in-vivo salivary 
levels of acetaldehyde produced by ethanol intake were significantly decreased by these 
tablets. It can be concluded that the buccal tablets here described represent an useful 
approach to the prevention of upper GI tract cancers ethanol-induced.  
